GPC-Rx Corp.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From GPC-Rx Corp.
Trevena Inc.
Trevena has carved out a niche in seeking so-called 'biased ligands'--GPCR-binding compounds that selectively activate just one (or a few) of the many biological pathways mediated via a particular GPCR complex. By identifying a ligand that hits the pathways responsible for a medicine's benefits, and avoiding those behind the ill effects, the company hopes to develop safer and more effective therapies, initially in CNS and cardiovascular disease.
Selected Start-Ups
In Vivo briefly describes these recently founded companies: AgileNano, Applied Catheter Technologies, Coromedic, EpiTherapeutics, GPC-Rx and RCP Therapeutics.
Emergings in Brief
Brief profiles of these recently formed companies: Coromedic, GPC-Rx, RCP Therapeutics, Reflectance Medical.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice